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Abstract
Background: Cellular contact with stimulated T cells is a potent inducer of cytokine production in human monocytes and is
likely to play a substantial part in chronic/sterile inflammatory diseases. High-density lipoproteins (HDL) specifically inhibit
the production of pro-inflammatory cytokines induced by T cell contact.
Methodology/Principal Findings: To further elucidate the pro-inflammatory functions of cellular contact with stimulated T
cells and its inhibition by HDL, we carried out multiplex and microarray analyses. Multiplex analysis of monocyte
supernatant revealed that 12 out of 27 cytokines were induced upon contact with stimulated T cells, which cytokines
included IL-1Ra, G-CSF, GM-CSF, IFNc, CCL2, CCL5, TNF, IL-1b, IL-6, IL-8, CCL3, and CCL4, but only the latter six were inhibited
by HDL. Microarray analysis showed that 437 out of 54,675 probe sets were enhanced in monocytes activated by contact
with stimulated T cells, 164 probe sets (i.e., 38%) being inhibited by HDL. These results were validated by qPCR. Interestingly,
the cytokines induced by T cell contact in monocytes comprised IL-1b, IL-6 but not IL-12, suggesting that this mechanism
might favor TH17 polarization, which emphasizes the relevance of this mechanism to chronic inflammatory diseases and
highlights the contrast with acute inflammatory conditions that usually involve lipopolysaccharides (LPS). In addition, the
expression of miR-155 and production of prostaglandin E2—both involved in inflammatory response—were triggered by T
cell contact and inhibited in the presence of HDL.
Conclusions/Significance: These results leave no doubt as to the pro-inflammatory nature of T cell contact-activation of
human monocytes and the anti-inflammatory functions of HDL.
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Introduction
Imbalance in cytokine homeostasis is thought to play an
important part in the pathogenesis of chronic inflammatory diseases
such as rheumatoid arthritis and multiple sclerosis. This suggests
that the mechanisms underlying the production of pro-inflamma-
tory cytokines and their natural inhibitors fail to undergo natural
regulation. In chronic/sterile immuno-inflammatory diseases, in the
absence of an infectious agent, the factors triggering pro-
inflammatory cytokine production are still elusive. We demonstrat-
ed that T cells may exert a pathological effect through direct cellular
contact with monocytes/macrophages, inducing massive up-
regulation of interleukin-1b (IL-1b) and tumor-necrosis factor
(TNF) [1–3].Indeed,the levelsofT cell contact-induced production
of IL-1b and TNF are comparable to those observed with optimal
doses of lipopolysaccharides (LPS), a stimulus related to acute/
infectious inflammation [2]. Besides triggering pro-inflammatory
cytokine production, contact-mediated activation of monocytes
induces the production and/or shedding of cytokine inhibitors such
as secreted IL-1 receptor antagonist (sIL-1Ra) and soluble receptors
of IL-1 and TNF [4–7]. Since T cells isolated from inflamed
rheumatoid arthritis synovium constitutively display the ability to
induce cytokine production in human monocytes in vitro [8], this
mechanism is likely to occur also in vivo and thus to be involved in
the pathogenesis of chronic inflammatory disorders leading to tissue
destruction. The importance of T cell contact-mediated activation
of monocytes/macrophages in chronic inflammatory conditions
was further borne out by the modulation occurring after drugs were
administered to patients for treatment. Indeed, interferon b (IFNb)
and glatiramer acetate, i.e., both immunomodulators used to treat
multiple sclerosis, modulate the production of IL-1b and sIL-1Ra in
T cell contact-activated monocytes in a manner that correlates with
measurements in treated patients [9,10]. This also applies to
leflunomide which is used to treat rheumatoid arthritispatients[11].
In chronic inflammation, after extravasation, most T cells remain
in the perivascular region, and other infiltrating cells such as
monocytes/macrophages and neutrophils have to cross the perivas-
cular layer of T cells to make contact with the latter cells before
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contact with T cells is less frequent outside perivascular regions.
However, cells can disseminate cell surface molecules by generating
microparticles and thus ensure ‘‘distant’’ cellular contact. Micropar-
ticles are fragments (0.1–0.8 mm diameter) shed from the plasma
membrane of stimulated or apoptotic cells. We recently determined
that microparticles generated by stimulated T cells display an ability
to activate monocytes that is similar to that displayed by membranes
ofstimulatedTcellsorsolubleextractsofthelatter[12].High-density
lipoproteins (HDL) specifically inhibit the induction of IL-1b and
TNF in monocytes activated by cellular contact with stimulated T
cells [13]. This anti-inflammatory function of HDL proved to be due
to their main protein component, apolipoprotein A–I (apo A–I),
which binds activating factors at the surface of stimulated T cells [13].
In vivo, apo A–I infiltration into inflamed rheumatoid arthritis joints
might lower the production of pro-inflammatory cytokines [14]. Of
note, contrary to the production of IL-1b and TNF, that of the anti-
inflammatorycytokine sIL-1Rainduced bycontactwith stimulated T
cells is not affected by HDL [12]. It follows that stimulated T cells
activate different monocyte functions by expressing surface mole-
cules. The activity of the latter may be inhibited or not by HDL.
This study was undertaken to identify molecules that are
induced in monocytes by cellular contact with stimulated T cells
and inhibited in the presence of HDL. The experimental approach
involved multiplex measurement of cytokines, chemokines and
growth factors produced by activated monocytes, as well as
microarray profiling. Studies of cell-cell interactions such as those
occurring in T cell contact-activation of human monocytes are
usually complicated by the simultaneous presence of at least two
viable cell types. To obviate this problem and possible interfer-
ences due to potentially phagocytic target cells, isolated mem-
branes from stimulated HUT-78 cells were solubilized and used as
a stimulus referred to as CEsHUT [9]. HUT-78 cells have
previously been shown to activate monocytes to a similar extent
as freshly isolated T lymphocytes [2]. The results show that direct
contact with stimulated T cells induces the expression of genes
mostly related to inflammatory pathways but different from those
induced under acute/infectious inflammatory conditions (e.g.,
induced by LPS), and that HDL inhibit the expression of pro-
rather than anti-inflammatory molecules.
Results
Apolipoprotein A–I Is the HDL Component Displaying
Inhibitory Activity
We previously demonstrated that apolipoprotein A–I was the
HDL component that inhibited T cell contact-activation of
monocytes [13]. Since HDL preparations may contain several
particle subpopulations, we first ascertained that the inhibitory
activity of the HDL preparation used in this study was due to apo
A–I. As shown in Figure 1, the inhibitory activity of HDL was
reversed in a dose-dependent manner by antibodies to apo A–I.
Antibodies to apo A–I alone did not affect IL-1b and TNF
production by human monocytes. Similarly, they did not change
CEsHUT-induced production of IL-1b or TNF in the absence of
HDL. Isotype IgG used as control did not display any effect (not
shown). This further confirms that apo A–I was indeed the
inhibitory component of HDL.
HDL Inhibit CEsHUT-Induced Inflammatory Cytokine
Production in Human Monocytes
To ascertain the anti-inflammatory functions of HDL in chronic
inflammatory conditions, human monocytes were activated by
CEsHUT in the presence or absence of HDL. Culture supernatants
were analyzed for the production of cytokines, chemokines and
growth factors using a 27-Plex kit (BioRad). Fifteen factors out of 27
were not significantly induced by CEsHUT, including cytokines
specifically produced by T cells(i.e.,I L - 2 ,I L - 4 ,I L - 5 ,I L - 9 ,I L - 1 3 ,a n d
IL-17), cytokines and chemokines produced by a variety of cells (i.e.,
IL-7, IL-10, IL-12, IL-15, CCL11 and CXCL10) and growth factors
(i.e., basic fibroblast growth factor – FGF, platelet-derived growth
factor- PDGF, vascular endothelialgrowth factor- VEGF).Asshown
in Figure 2, the production of 12 out of 27 measured factors was
induced by CEsHUT including IL-1b, TNF and IL-1Ra. In contrastto
sIL-1Ra production, that of IL-1b and TNF was inhibited by HDL
(Figure 2A), corroborating previous results. In addition, CEsHUT
induced monocytes to produce factors involved in their localization,
survival and differentiation such as CCL5 (RANTES), CCL2 (MCP-
1), interferon-c (IFNc), granulocyte-macrophage colony-stimulating
factor (GM-CSF), and macrophage-CSF (M-CSF). The production
ofthelatterwasmoderateanditwasnotaffectedbyHDL(Figure2B).
In contrast, CEsHUTstrongly induced the production of cytokines and
chemokines that display robust pro-inflammatory functions, i.e.,I L - 6 ,
IL-8, CCL3 (MIP-1a)a n dC C L 4( M I P - 1 b), the latter being inhibited
i nt h ep r e s e n c eo fH D L( F i g u r e2 C ) .T h e s ed a t ad e m o n s t r a t et h a t
direct cellular contact with stimulated T cells (mimicked by CEsHUT)
induced the production of many factors in addition to that of IL-1b,
TNF and sIL-1Ra that had previously been studied. However,
CEsHUT was not a general activator of monocytes, it rather activated
specific pathways relevant to inflammation. The premise that HDL
mainly inhibited pro-inflammatory rather than anti-inflammatory
factors strengthens the claim to their anti-inflammatory functions.
Together, these results suggest that CEsHUT triggered the expression
of multiple factors in human monocytes, some of whose expression
was modulated by HDL. This prompted us to conduct a microarray
analysis to define genes whose expression was triggered by CEsHUT
and inhibited in the presence of HDL.
Modulation of IL-1b Transcript Expression by CEsHUT and
HDL
Microarray analysis was carried out with monocytes prepared
from 3 different human donors. The activation stage of monocytes
Figure 1. Apo A–I mediates the inhibitory effects of HDL in T
cell contact-induced cytokine production in monocytes. Mono-
cytes (5610
4 cells/200 ml/well; 96-well plates) were activated (closed
symbols) or not (open circles) by CEsHUT for 24 h in the presence
(triangles) or absence (circles) of HDL. Cell culture supernatants were
tested by Quantikine kits (R&D) for the presence of IL-1b and TNF.
Results are expressed as mean6SD of a representative experiment
carried out in triplicate.
doi:10.1371/journal.pone.0009418.g001
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modulations in the present settings are well known [12,13]. As shown
by qPCR, CEsHUT induced the expression of IL-1b mRNA in the 3
monocyte preparations (Figure 3A). Although they differed depend-
ing on monocyte preparation, the IL-1b transcript levels were more
than 2-fold higher in monocytes activated by CEsHUT than in resting
monocytes. In the presence of HDL, the CEsHUT-induced IL-1b
transcript levels of donors a and b reverted to basal levels (Figure 3Aa
and 3Ab) while those of donor c were inhibited by 83% Figure 3Ac).
Although these data validated the experiments for microarray
analysis, the induction of IL-1b transcript levels differed from that
observed by qPCR (Figure 3B). Indeed, none of the two IL1B probe
sets generated signal enhancement or inhibition by HDL that
reached the 2-fold cut-off in any of the monocyte preparations,
although the mean enhancement (1.55- and 1.48-fold) induced by
CEsHUT reverted completely in the presence of HDL. However,
levels of the TNF transcript as determined by microarray analysis
were similar to those previously obtained by qPCR [12], validating
monocyte activation by CEsHUT and inhibition by HDL in the 3
experiments. The discrepancy between qPCR and microarray
measurements of IL-1b transcript levels was likely to be due to high
signal values observed in resting monocytes for the 2 IL1B probe sets
in microarray analysis (Figure 4). With such saturating signals,neither
enhancement nor inhibition couldbe determined with accuracy. This
was not true for TNF and two out of five IL-1Ra probe sets that were
in the range where signal variations were optimal (Figure 4).
Comparison of Microarray Analysis of Gene Expression
with Protein Production
In order to corroborate results from measuring protein
production and gene expression, results shown in Figure 2 were
compared to those of microarray analysis. There was no
enhancement of gene expression for cytokines, chemokines and
growth factors that were not detected in supernatants of CEsHUT-
activated monocytes (i.e., IL-7, IL-10, IL-12, IL-15, CCL11, FGF,
and VEGF) with the exception of PDGF-b and CXCL10. Indeed,
the signals of PDGFB and CXCL10 probe sets were enhanced
respectively by factors of 2.8860.26 and 20.09621.42 in
monocytes activated by CEsHUT (Table S1), whereas proteins
did not reach the detection limit in cell supernatants. This
discrepancy could not be explained for CXCL10; however, the
premise that PDGF is a heterodimer of PDGF-a and -b and
PDGFA transcript remained undetectable in both resting and
activated monocytes, might explain that PDGF was not detected
in monocyte supernatants. In contrast, signals of probe sets for
CCL5, G-CSF (CSF3) and GM-CSF (CSF2) that were measured in
supernatants of CEsHUT-activated monocytes were not increased.
This might be due to the time-course of the latter gene expression,
the transcript being measured after 3 h of monocyte activation
and that of secreted proteins after 24 h. Thus, the transcription of
these genes might be delayed. Interestingly, factors displaying anti-
inflammatory functions such as IL-10 and TGFb were not
induced, the signal of the TGFB probe set being even diminished
2.84-fold (Table S1). The probe set of IL-23 a-subunit (IL23A) was
enhanced 18.24-fold, whereas IL-23 was not detectable in
supernatants of CEsHUT-activated monocytes. This was not due
to an incapacity of monocytes to produce IL-23, since the same
monocyte preparations yielded 7816572 pg/ml IL-23 (mean 6
SD, n=3) when activated by 100 ng/ml LPS (not shown).
Interestingly, probe sets for IL-12 a- and b-subunits were not
detected in either resting or CEsHUT-activated monocytes, further
suggesting that the active form of IL-23 which is composed of a
dimer of IL-23 a-subunit and IL-12 b-subunit was not produced
by CEsHUT-activated monocytes. Together, these results corrob-
Figure 2. Modulation of cytokine production by HDL in CEsHUT-activated monocytes. Monocytes (5610
4 cells/200 ml/well; 96-well plates)
were activated by CEsHUT for 24 h in the presence (empty columns) or absence (grey columns) of HDL. Cell culture supernatants were tested for the
presence of the indicated cytokines by BioPlex using a 27-Plex kit. Results were obtained from monocytes isolated from 3 individual donors and are
expressed as mean 6 SD (n=3). (A) Cytokines previously shown to be modulated by CEsHUT; (B) CEsHUT-induced cytokines whose expression was not
modulated by HDL; and (C) CEsHUT-induced cytokines whose expression was inhibited in the presence of HDL.
doi:10.1371/journal.pone.0009418.g002
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activated monocyte supernatants (Figure 2).
HDL Mainly Affect the Expression of Molecules Related to
Inflammation in CEsHUT-Activated Monocytes
Microarray analysis was carried out with the following criteria:
1) since signals differ greatly as a function of monocyte
preparation we proceed to paired comparisons within experi-
ment carried out with the same monocyte preparation; 2) probe
sets with signals ,100 in the CEsHUT-activated condition were
discarded considered as not different from background; and 3)
only probe sets with fold changes #22.0 or $2 . 0i na tl e a s t2o u t
of the 3 experiments were considered as affected by CEsHUT.B y
using this strategy, 666 probe sets were identified that were either
enhanced (437, i.e., 66%) or decreased (229, i.e., 34%) upon
monocyte activation by CEsHUT (Figure 4; complete list in Table
S 1 ) .I nt h ep r e s e n c eo fH D L ,1 1 0 1p r o b es e t sw e r em o d u l a t e d ,
48% (524 probe sets) being increased and 52% (577 probe sets)
decreased in [CEsHUT + HDL]-activated monocytes (complete
list in Table S2). The premise that genes modulated by CEsHUT
in the presence of HDL were more numerous than in the absence
of HDL suggests that the expression of many genes was
hampered upon T cell contact-activation of monocytes. Notice-
ably, 104 genes were significantly induced by CEsHUT and not by
[CEsHUT + HDL], whereas 168 genes were increased by
[CEsHUT + HDL] and not by CEsHUT. Ingenuity Pathway
Analysis (IPA) for genes whose expression was exclusive to one or
the other condition demonstrate that genes induced by CEsHUT
were mainly related to inflammation whereas this correlation was
poorer for genes uniquely induced by [CEsHUT + HDL], both in
terms of gene number and fitting to IPA defined pathways, i.e.,p -
values (Table 1). HDL per se affected the expression of only 92
probe sets (39 increased, 53 decreased) in human monocytes (see
Figure 3. Inhibition by HDL of CEsHUT-triggered IL-1b mRNA.
Monocytes (7610
6 cells/P-100mm/6 ml) isolated from 3 different donors
(a, b and c) were activated by CEsHUT (6 mg/ml) in the presence (empty
columns) or absence (grey columns) of HDL (0.2 mg/ml) for 3 h. (A)
Isolated RNA was subjected to qPCR to assess IL-1b transcript levels.
Results are presented as mean 6 SD of triplicates. (B) Isolated RNA was
subjected to microarray analysis. Results are expressed as mean 6 SD,
n=3.
doi:10.1371/journal.pone.0009418.g003
Figure 4. Analysis of gene expression in monocytes activated by CEsHUT. Total RNA was used in Affymetrix microarrays to analyse gene
expression. The scatter plot (GeneSpring) shows the amounts expressed in CEsHUT-activated monocytes (y-axis) as a function of amounts expressed in
resting monocytes (x-axis), applying a cut-off of 2.0. Each dot represents one probe set; probe sets for IL-1b, IL-1Ra and TNF are indicated. Probe sets with
signals below 100 were discarded (dashed lines). Using the latter criteria, 437 probe sets were up-regulated, and 229 down-regulated as indicated.
doi:10.1371/journal.pone.0009418.g004
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displayed high basal expression in resting monocytes (Figure 3
and 4). To take into account basal signals, we chose to compare
signal ratios (fold changes) of ‘‘CEsHUT versus medium’’
condition to ‘‘[CEsHUT + HDL] versus medium’’ condition by
pair, i.e., fold changes in ‘‘CEsHUT versus medium’’ condition
were compared to fold changes in ‘‘[CEsHUT + HDL] versus
medium’’ condition in each experiment and the mean value was
taken into account to determine the difference in probe set signals
induced by CEsHUT alone or by CEsHUT in the presence of HDL.
As presented in Table S4, 164 probe sets representing 113
molecules displayed $1.4-fold higher levels in [CEsHUT]t h a ni n
[CEsHUT + HDL] condition demonstrating that their induced
expression was inhibited by HDL. To validate these results and
our calculation strategy, genes were chosen from Table S4 and
subjected to transcript level measurement by qPCR (Table 2). In
addition, IL-1b and IL-8 were added to this list because they both
displayed high basal signals in microarray analysis and their
protein production was modulated by HDL (Figure 2 and
Table 2). As shown in Figure 5, transcripts of the 23 chosen genes
were all significantly increased in monocytes activated by
CEsHUT thus correlating microarray results. Eighteen out of 23
transcripts were inhibited in the presence of HDL. Noticeably,
HDL per se diminished the levels of several transcripts in
‘‘resting’’ monocytes including CCL3 and CCL4 (Figure 5), thus
correlating results of Table S3. However, the transcript
expression of 5 genes, i.e., IL1RN, CISH, HAS1, ADAP1/
CENTA1,a n dICAM1 was not inhibited in the presence of
HDL (Figure 5B). These genes displayed different expression
patterns when measured by qPCR or by microarray analysis. No
obvious reason could be determined for this discrepancy.
HDL Inhibit the CEsHUT-Induced Expression and Secretion
of Non-Protein Compounds
CEsHUT not only induced the transcription of genes encoding
proteins but also that of non-protein-coding genes such as
MIRHG2/BIC which is inhibited in the presence of HDL (Table
S4). MIRHG2/BIC is the microRNA host gene 2 which contains
miR-155. In acute inflammation, miR-155 expression is induced
Table 1. IPA Pathways Associated with Genes whose
Expression is Exclusive to [CEsHUT] or [CEsHUT + HDL].
Condition Diseases and Disorders p-value* number
[CEsHUT] Inflammatory Response 5.2610
29–2.85610
23 25
Inflammatory Diseases 1.66610
27–2.82610
23 32
[CEsHUT + HDL] Inflammatory Response 1.22610
24–9.52610
23 23
Inflammatory Diseases 1.16610
23–9.52610
23 11
The 104 genes increased exclusively in monocytes activated by CEsHUT ([CEsHUT])
and the 168 genes increased exclusively in monocytes activated by CEsHUT in
the presence of HDL ([CEsHUT + HDL]) were subjected to IPA analysis. The table
displays the number of genes related to inflammation. The significance is
expressed as range of p values based on Fisher’s exact test.
doi:10.1371/journal.pone.0009418.t001
Table 2. Genes Chosen for Validation by qPCR.
Affymetrix ID Gene Symbol Description
Induction by CEsHUT
(fold change)
Inhibition by
HDL (fold change)
90265_at ADAP1/CENTA1 Arf-GAP with dual PH domain-containing protein 1 (centaurin, a 1) 2.30 22.23
205114_s_at CCL3 Chemokine (C-C motif) ligand 3 3.89 21.55
204103_at CCL4 Chemokine (C-C motif) ligand 4 2.64 22.00
223961_s_at CISH Cytokine inducible SH2-containing protein (CIS) 4.91 22.29
209716_at CSF1 Macrophage-colony stimulating factor 1 (M-CSF) 10.86 25.19
226201_at DOT1L Histone-lysine N-methyltransferase, H3 lysine-79 specific 2.17 22.90
208893_s_at DUSP6 Dual specificity phosphatase 6 3.78 22.21
222802_at EDN1 Endothelin 1 5.03 23.80
207316_at HAS1 Hyaluronan synthase 1 3.52 21.95
202638_s_at ICAM1 Intracellular adhesion molecule 1 (CD54) 2.22 21.90
212659_s_at IL1RN Interleukin-1 receptor antagonist 3.69 24.30
205207_at IL6 Interleukin-6 3.18 21.70
204926_at INHBA Inhibin, beta A (activin A, activin AB alpha polypeptide) 8.38 22.17
1560397_s_at KLHL6 Kelch-like 6 2.31 22.63
206267_s_at MATK Megakaryocyte-associated tyrosine kinase 3.60 23.09
207091_at P2RX7 P2X purinoceptor 7 (ATP receptor) 2.77 21.53
210845_s_at PLAUR Urokinase plasminogen activator surface receptor 2.57 21.41
209325_s_at RGS16 Regulator of G-protein signaling 16 11.15 24.36
238729_x_at SAV1 Protein salvador homolog 1 10.18 22.26
204011_at SPRY2 Protein sprouty homolog 2 24.82 22.02
207113_s_at TNF Tumor necrosis factor a 7.85 22.06
205067_at IL1B Interleukin 1b 1.55 21.42
202859_x_at IL8 Interleukin 8 1.30 21.31
doi:10.1371/journal.pone.0009418.t002
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LPS-activated dendritic cells [15]. Since miR-155 plays an
important part in inflammatory processes, its induction by
CEsHUT and inhibition by HDL were assessed by qPCR. As
illustrated in Figure 6A, miR-155 expression was indeed induced
by CEsHUT and inhibited in the presence of HDL, thus validating
the microarray results (Table S4). Furthermore, CEsHUT induced
the expression of enzymes involved in the synthesis of non-protein
pro-inflammatory compounds such as eicosanoids. To determine
whether the induction of cyclooxygenase-2 (COX-2) transcript by
CEsHUT and its inhibition by HDL (Table S4) were associated with
the expression of a functional enzyme, we tested monocyte
supernatants for the production of its product, i.e., prostaglandin
E2 (PGE2). As shown in Figure 6B, CEsHUT-activated monocytes
did indeed produce PGE2, which production was inhibited in the
presence of HDL. Together, the results presented in Figure 6
further point to contact with stimulated T cells as a pro-
inflammatory stimulus of monocytes that does not only induce
cytokines but also non-protein components such as microRNAs
and prostaglandins related to inflammation.
HDL Inhibited the Expression of Genes Involved in
Inflammatory Processes
In order to establish that HDL mainly affected inflammatory
functions, we run an IPA comparing the following conditions:
CEsHUT versus medium (666 probe sets) and [CEsHUT+HDL]
versus medium (1101 probe sets, Table S2). The analysis
revealed that among the biofunctions that were modulated by
cellular contact with stimulated T cells, those that were
inhibited by HDL related mainly to inflammation and
immunity (Figure 7). Of the genes associated with ‘‘Diseases
and Disorders’’ (according to IPA), those correlated to
inflammatory response and inflammatory diseases in CEsHUT
(p-values between 5.25610
220 and 1.28610
25) were a better
m a t c ht h a nt h o s ei n[ C E sHUT + HDL] (p-values between
7.52610
29 and 6.42610
25). Of note, genes related to
rheumatoid arthritis, atherosclerosis and multiple sclerosis were
also attributed by IPA to ‘‘Connective Tissue Disorders’’,
‘‘Cardiovascular Disease’’, and ‘‘Neurological Disease’’, re-
spectively. These genes proved to be a better match in the
[CEsHUT] conditions than in the [CEsHUT + HDL] conditions.
Figure 5. qPCR assessment of selected transcripts to validate microarray results. Several genes listed in Table S4 were selected and RNA,
isolated from the 3 monocyte preparations, was subjected to qPCR. (A) Genes that were validated (i.e., those displaying similar behavior as in
microarray analysis). (B) Genes that were not validated. Results were normalized to fully activated condition (CEsHUT), considered to be 1. Data are
expressed as mean 6 SD, n=3; ** p,0.01; * p,0.05.
doi:10.1371/journal.pone.0009418.g005
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tion-related genes in monocytes activated by CEsHUT. Genes
implicated in cell survival and metabolism, including those
related to ‘‘cell growth and proliferation’’, ‘‘cell death’’, and
‘‘cell cycle’’, were only modulated to a small extent or not at all
i nt h ep r e s e n c eo fH D L( F i g u r e7 B ) .T h e s er e s u l t ss u g g e s tt h a t ,
in human monocytes, CEsHUT mainly affected the expression of
molecules related to inflammation and that their expression was
inhibited in the presence of HDL. IPA of probe sets, whose
signals were increased by CEsHUT and decreased by HDL
(Table S4), revealed that genes whose CEsHUT-induced
expression was inhibited by HDL were mainly involved in
inflammatory diseases and disorders (Table 3). The global
outcome of the IPA of microarray results suggests that CEsHUT
mainly affected inflammatory and immune functions in human
monocytes and that HDL opposed these functions due to its
inhibitory effect.
Discussion
This study demonstrates that activation of monocytes by cellular
contact with stimulated T cells as mimicked by CEsHUT is a pro-
inflammatory mechanism distinct from that induced by LPS. In
addition to the prototypical pro-inflammatory cytokines IL-1b and
TNF, CEsHUT induces the expression of many genes related to
inflammatory processes, thus generating a microenvironment
which may contribute to TH17 polarization. HDL does not
randomly inhibit T cell contact-activated monocytes but specifi-
cally inhibit CEsHUT-induced pro-inflammatory genes. In contrast,
HDL do not affect or inhibit - or only to a small extent - the
Figure 6. HDL inhibit miR-155 expression and PGE2 production induced by CEsHUT in human monocytes. (A) Total RNA isolated from
monocytes activated (CEsHUT) or not (medium) in the presence (white columns) or absence (grey columns) of HDL and subjected to qPCR analysis for
the presence of miR-155. (B) Monocytes were activated as in Figure 2, and PGE2 production measured in cell supernatants. Results are expressed as
mean 6 SD of 3 different experiments.
doi:10.1371/journal.pone.0009418.g006
Figure 7. HDL inhibit inflammatory functions induced by CEsHUT in human monocytes. Microarray results of [CEsHUT] versus medium (grey
columns) and [CEsHUT + HDL] versus medium (empty columns) were subjected to comparative analysis in the IPA system. (A) Genes related to
‘‘Diseases and Disorders’’; (B) genes related to ‘‘Molecular and Cellular Functions’’.
doi:10.1371/journal.pone.0009418.g007
HDL Inhibition of Inflammation
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tory functions.
According to Multiplex analysis of soluble factors induced by
CEsHUT, of the important pro-inflammatory factors, IL-12 is not
produced by activated human monocytes. This is substantiated by
microarray analysis which failed to reveal transcripts for IL-12p40
(IL12B) or IL-12p35 (IL12A) in both resting and CEsHUT-activated
monocytes. This suggests that T cell contact-mediated activation
of monocytes does not generate a cytokine environment propitious
to TH1 polarization [16]. IL-1b and IL-6 however, which are
involved in TH17 differentiation [17], are highly induced by
CEsHUT in monocytes (Figure 2), suggesting that contact with
stimulated T cells might result in a bias towards pro-inflammatory
TH17 cells [18]. This is particularly important in view of recent
results showing that TH17 rather than TH1 cells display
pathogenic functions in chronic inflammatory diseases such as
multiple sclerosis and rheumatoid arthritis [19]. Interestingly, LPS,
i.e., the prototypical stimulus of acute inflammation, induces IL-12
in human monocytes [20], thus distinguishing the latter inflam-
matory mechanism from chronic/sterile inflammation which
implicates contact with stimulated T cells. Together these
observations suggest that T cell contact-activated monocytes
might generate a cytokine microenvironment inclined to give rise
to a bias towards TH17 at the inflammatory site.
IL-10, whose production is induced upon human monocyte
activation by LPS [21], was not detected in CEsHUT-activated
monocyte supernatants, nor was its transcript detected (i.e., signal
,100) in microarray analysis. These results are reminiscent of
previous data showing that IL-10 mRNA was not expressed in
monocytes activated by membranes of stimulated T cells for 1 or
24 h [22]. Similarly, cytokine-stimulated T lymphocytes, which
are comparable to rheumatoid arthritis synovium T lymphocytes
[8], fail to trigger IL-10 production in monocytes [23], but not in
M-CSF-differentiated macrophages [24]. Together these observa-
tions suggest that T cell contact-induced IL-10 production
depends on the differentiation stage of monocytes/macrophages.
Since IL-10 is involved in the reduction and resolution of
inflammation [25], its lack of production upon T cell contact-
activation of monocytes might explain in part the persistence of
inflammation in chronic, destructive inflammatory diseases.
The microarray analysis of CEsHUT-activated monocytes also
identified the up-regulation (4.75-fold) of the MIRHG2/BIC probe
set. MIRHG2/BIC is the host gene of miR-155. The expression of
miR-155 was validated by qPCR (Figure 6), demonstrating the
enhancement of miR-155 expression (4.2260.2-fold) upon
CEsHUT-activation of human monocytes and its inhibition to
basal levels in the presence of HDL. MicroRNAs have emerged as
a major class of gene expression regulators linked to most
biological functions. MiR-155 is up-regulated by LPS and other
inflammatory mediators [26]. Recently, miR-155 has been
identified as a regulator of the Toll-like receptor/interleukin-1
(TLR/IL-1) signalling pathway [15]. Of note, the production of
IL-1b and TNF was lower in human miR-155 knock-down
dendritic cells than in untransfected cells [15]. Thus, the premise
that CEsHUT induces the expression of miR-155 which is
diminished in the presence of HDL (Tables S1 and S4) lends
additional weight to its classification as a pro-inflammatory
mechanism. Other genes involved in mRNA stability are induced
upon CEsHUT-activation of monocytes; they include the exosome
component RRP41 [27], whose probe set (EXOSC4) levels are
inhibited in the presence of HDL.
In addition to cytokines, chemokines and growth factors
(Figure 2) COX-2 transcript expression was enhanced 4.88-fold
in monocytes activated by CEsHUT, suggesting that human
monocytes activated by CEsHUT may produce eicosanoids.
CEsHUT induced the production of PGE2 in monocytes, which
was inhibited by HDL (Figure 6). This is in keeping with the
premise that COX-2 expression was inhibited in the presence of
HDL (Table S4). Together, these data suggest that HDL may
inhibit the CEsHUT-induced synthesis of eicosanoids, which
constitutes an additional argument in favor of their anti-
inflammatory action. Since PGE2 is also involved in TH17
polarization and maintenance [28], this result support the
hypothesis that CEsHUT-activated monocytes may generate a
microenvironment propitious to the generation of TH17 cells.
The production of IL-1b is tightly regulated at several levels by
‘‘roadblocks’’ as defined by Dinarello [29]. The latter include the
facilitation of IL-1b processing by the caspase-1 inflammasome
through ATP activation of the P2X7 receptor. As shown in Table
S4, the transcription of genes whose proteins are involved in IL-1b
processing and secretion was induced by CEsHUT and inhibited in
the presence of HDL. Indeed, CIAS1/NLRP3 and P2RX7 genes that
code for NALP-3 and P2X7 receptor - both involved in the IL-1b
secretion process [30] - are induced 3.01- and 2.77-fold,
respectively, upon CEsHUT-activation, and inhibited in the presence
of HDL (Tables S1 and S4). This demonstrates that in addition to
inducing the IL-1b transcript, cellular contact with stimulated T
cells triggers processes that underlie optimal/detrimental produc-
tion of IL-1b upon chronic/sterile inflammatory conditions.
The present microarray results were obtained from monocytes
activated by CEsHUT for 3 h. Although genes might be up- or down-
modulated at other time-points, the results of multiplex and ELISA
validated most of results seen with cytokine transcripts. Modulation of
highly expressed genes (i.e., displaying saturating, basal signals higher
than 10,000) like IL-1b and IL-8 might be similarly regulated but are
outside the range of the present analysis. However, these consisted
mainly of ribosomal protein transcripts. Of the transcripts that might
be regulated by extracellular signals, only two were likely to be
Table 3. IPA Pathways Associated with Genes whose CEsHUT-
Induced Expression is Inhibited by HDL.
Diseases and Disorders p-value number
Cancer 9.19610
217–
2610
26
59
Inflammatory Diseases 2.51610
211–
2.35610
26
41
Hematological Diseases 2.4610
211–
2.19610
26
33
Inflammatory Response 1.97610
215–
2.35610
26
32
Connective Tissue Disorders or Skeletal and
Muscular Disorders
2.59610
210–
1.91610
26
29
Reproductive System Diseases 1.06610
210–
1.87610
26
28
Neurological Diseases 1.67610
29–
1.53610
26
27
Immunological Diseases 2.4610
211–
2.19610
26
25
Genetic Disorders 2.59610
210–
2.35610
26
25
Dermatological Diseases and Conditions 8.58610
212–
1.11610
26
21
Cardiovascular Diseases 4.41610
210–
1.94610
26
20
doi:10.1371/journal.pone.0009418.t003
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IER3 (immediate early response 3) and FTH1 (ferritin, heavy
polypeptide 1). We thus conclude that this analysis includes all genes
of interest that are modulated by contact with stimulated T cellsat 3 h.
In conclusion, the present results demonstrate that direct
cellular contact with stimulated T cells induces pro-inflammatory
factors and pathways in human monocytes and that HDL
modulates these pathways to take on a less inflammatory pattern.
CEsHUT-activation of monocytes induces conditions that may
favor a bias toward TH17 in neighboring T cells. Interestingly,
mechanisms able to induce a cytokine environment favoring such
a bias, i.e., inflammatory mechanisms which do not induce IL-12
production, have been poorly described although TLR2 ligands
such as zymosan might favor IL-23 rather than IL-12 production
[31]. This highlights the importance of this mechanism in
chronic/sterile inflammatory diseases such as multiple sclerosis
and rheumatoid arthritis, and in turn the role of its specific
inhibition by HDL. Activation of human monocytes by contact
with stimulated T cells might be a clue to the mechanisms
underlying systemic chronic/sterile inflammatory conditions
which remain poorly understood, but clearly do not seem to fit
the classical pattern of transition from acute to chronic
inflammation [32,33].
Materials and Methods
Materials
Fetal calf serum (FCS), streptomycin, penicillin, L-glutamine,
RPMI-1640, and PBS free of Ca
2+ and Mg
2+ (Gibco, Paisley,
Scotland); purified phytohemagglutinin (PHA) (EY Laboratories,
San Marco, CA); TriReagent, phorbol myristate acetate (PMA),
polymyxin B sulfate (Sigma Chemicals Co., St. Louis, MO); and
goat anti-apolipoprotein A–I antibodies and IgG (Academy Bio-
medical Co.) were purchased from the designated suppliers. Other
reagents were of analytical grade or better.
Monocytes
Peripheral blood monocytes were isolated from buffy coats of
healthy blood donors as previously described [13]. In order to rule
out activation by endotoxins, polymyxin B (2 mg/ml) was added to
all solutions during the isolation procedure.
T Cell Stimulation, and Plasma Membrane Isolation and
Solubilization
The human T cell line HUT-78 was obtained from the ATCC
(Rockville, MD). Cells were maintained in RPMI-1640 medium
supplemented with 10% heat-inactivated FCS, 50 mg/ml strepto-
mycin, 50 IU/ml penicillin and 2 mM L-glutamine in 5% CO2-
air humidified atmosphere at 37uC. HUT-78 cells (2610
6 cells/
ml) were stimulated for 6 h by PHA (1 mg/ml) and PMA (5 ng/
ml). Plasma membranes of stimulated or unstimulated HUT-78
cells were prepared and solubilized in 8 mM CHAPS as previously
described [9,34]. CHAPS extracts of membranes from stimulated
HUT-78 cells were referred to as CEsHUT [12].
Isolation of HDL
Human serum HDL were isolated as previously described [13].
In order to optimize the inhibitory effect of HDL, they were mixed
with the stimulus prior to addition to monocytes.
Cytokine Production
Monocytes (5610
4 cells/well/200 ml) were activated or not with
6 mg/ml CEsHUT in RPMI 1640 medium supplemented with 10%
heat-inactivated FCS, 50 mg/ml streptomycin, 50 U/ml penicillin,
2 mM L-glutamine and 5 mg/ml polymyxin B sulfate (medium) in
96-well plates and cultured for 24 h. The production of cytokines
was measured in culture supernatants by Bio-PlexH analysis
(Human Cytokine 27-Plex Panel, BioRad). Alternatively, some
cytokines were determined by commercially available kits,
QuantikineH from R&D.
PGE2 Production
Monocytes (5610
4 cells/well/200 ml) were activated or not with
6 mg/ml CEsHUT in RPMI 1640 medium supplemented with 10%
heat-inactivated FCS, 50 mg/ml streptomycin, 50 U/ml penicillin,
2 mM L-glutamine and 5 mg/ml polymyxin B sulfate (medium) in
96-well plates and cultured for 24 h. The production of PGE2 was
measured as described previously [35].
Quantitative Real-Time PCR
Quantitative real-time duplex PCR analysis (qPCR) was
conducted as previously described [36]. The mRNA expression
levels were normalized with the expression of a housekeeping gene
(18S) analyzed simultaneously. All probes were purchased from
Applied Biosystems. Measurements were conducted in triplicates.
miR-155 presence was ascertained by a commercially available kit
(TaqMan MicroRNA assay, has-miR-155, Applied Biosystems)
according to supplier’s instructions.
Microarray Analysis
Fourteen million of human monocytes (7610
6 cells/100 mm
petri dish/6 ml) isolated from 3 normal blood donors were
activated or not for 3 h by 6 mg/ml CEsHUT in the presence or
absence of 0.2 mg/ml HDL. When CEsHUT was not added, its
volume was compensated by PBS containing 8 mM CHAPS.
Total RNA was isolated and processed using the RNeasy
extraction kit (Qiagen), according to manufacturer’s protocol.
RNA was tested for integrity by capillary electrophoresis (2100
Bioanalyzer, Agilent) and used for the synthesis of biotin-labeled
cRNA in accordance with the two-cycle target labeling protocol
developed by Affymetrix (GeneChipH Eukaryotic Small Sample
Target Labeling Assay Version II, Affymetrix). Biotin-labeled
cRNA was hybridized to Affymetrix GeneChipH HG-U133 plus
2.0 containing 54,675 distinct probe sets. Three chips were
hybridized and scanned, each corresponding to one donor, for
each condition. Signal values and detection calls (present, marginal
or absent) for each probe set were determined using the Affymetrix
MAS5.0 algorithm. When required, the resulting lists of genes
were subjected to analysis by Ingenuity Pathway Analysis (IPA,
version 7.5, http://www.ingenuity.com/). IPA is a software
application for associating genes that are part of a common
regulatory biological network and thus for setting up, analyzing
and understanding complex biological systems.
Statistics
Where required, significance of differences between groups was
assessed using Student’s t test.
Supporting Information
Table S1 Probe sets whose signal was modified in the presence
of CEsHUT.
Found at: doi:10.1371/journal.pone.0009418.s001 (1.33 MB
DOC)
Table S2 Probe sets whose signal was affected in the presence of
CEsHUT and HDL.
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Table S3 Probe sets whose signal was modulated by HDL.
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Table S4 Probe sets whose signals was lower in monocytes
activated by CEsHUT + HDL than in monocytes activated by
CEsHUT.
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DOC)
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